<<
>>

Tuberculosis Caused by M. bovis in Humans in Uganda

In humans, TB is mostly caused by Mycobacterium tuberculosis; however, M. bovis remains an important pathogen capable of infecting and causing clinical disease (zoonotic TB) in humans (See Chap.

3). The lack of routine surveillance for M. bovis as the causal agent of human TB in most of the developing world (Cosivi et al. 1998; Muller et al. 2013) represents an important challenge to our understanding of the true global burden of zoonotic TB. This is also the case for Uganda, in which the systemic lack of surveillance for zoonotic TB most likely results in underestimating the true burden of this disease. From a public health perspective, defining the role of M. bovis (and environmental mycobacteria) as a causal agent of human TB in developing countries such as Uganda is critical, but it has become increasingly difficult because of financial and technical constraints and disregard of its impor­tance to obtain the required information by the governmental regulatory authorities.

22.5.1 Diagnosis of Zoonotic Tuberculosis

Direct microscopic examination of sputum specimen is the most widely used method for TB screening in humans in Uganda. This approach presents an important obstacle because direct microscopy does not differentiate between M. tuberculosis and M. bovis. Additionally, zoonotic TB mostly presents as extrapulmonary TB (Cosivi et al. 1998; Durr et al. 2013). As only sputum samples are customarily examined, cases with extrapulmonary lesions are not detected.

The correct identification of M. bovis as a causal agent of TB in humans is important especially in rural communities in which BTB is endemic in the local cattle populations. In such areas, sociocultural practices create close interaction between livestock and humans, thus increasing the probability of direct and indirect transmission of M. bovis from livestock (and their products) to humans.

From a public health perspective, it is critical to identify patients with TB infected with M. bovis, because it differs from that of M. tuberculosis by being naturally resistant to pyrazinamide. Thus, zoonotic TB patients require longer treatment regimens and are inadequately treated if M. bovis is not identified. Additionally, because of the attrition that occurs during protracted treatment periods, antimicrobial resistance is more likely to develop in M. bovis (Durr et al. 2013).

The epidemiology and transmission dynamics of M. bovis to humans differ considerably from M. tuberculosis, which is mostly transmitted by spread of aerosol droplets during coughing and sneezing. These differences ought to be reflected in the diagnostic regimen used, but unfortunately in Uganda, sensitive and specific diag­nostic tests to correctly identify M. bovis as the causal agent of TB in humans are not readily available in rural areas. It is therefore not surprising that most of the reported zoonotic TB cases in Uganda are the results of individual research projects (Oloya et al. 2008; Nasaka 2014) rather than of the national TB surveillance programs. These reports showed that the prevalence of zoonotic TB ranges from 1.4% to 6.9% in various parts of the UCC. There have been efforts to patch these holes (Bretzel et al. 1999), but to acquire accurate and more comprehensive estimates of the true burden of zoonotic TB in Uganda, a holistic One Health approach, involving the Ministries of Health and Agriculture, Animal Industry and Fisheries, the National TB program, National Animal Disease Diagnostics, and the National Epidemiology Centre, is needed to conduct adequate surveillance programs using adequate diag­nostic techniques.

22.5.2 Mycobacterial Culture

Mycobacterial culture is performed in four laboratories, three of which are located in the capital city, Kampala. These include the National TB Program Laboratory (under the Ministry of Health), the laboratory at the Makerere University Teaching Hospital, and the HIV/AIDS Research-Oriented TB Culture Laboratory (Everett et al.

2010; Ssengooba et al. 2015). This urban localization of the sophisticated diagnostic infrastructure means that it is out of reach of rural communities, mainly because of the cost implications related to accessibility. The fourth TB culture laboratory is in the western part of the country, at the Mbarara University Teaching Hospital, which operates under the same remit as the three laboratories in Kampala.

22.5.3 Molecular Typing Tools

Molecular typing is the process by which different types of organisms within a species are identified (Sabat et al. 2013). Spacer Oligonucleotide typing (spoligotyping) and MIRU-VNTR are the two commonly used molecular methods to type mycobacteria in Uganda. The former is reported to be highly reproducible with results that allow inter-laboratory comparison, but it has low discriminatory power, and it can produce homoplasy (Rodriguez-Campos et al. 2011). In Uganda, it is used to differentiate between members of the MTC including M. bovis (Asiimwe et al. 2009) and for predicting TB transmission patterns (Lukoye et al. 2014). MIRU- VNTR analysis was introduced in Uganda in 2010 and is used mainly to detect multiple infection and transmission patterns (Dickman et al. 2010). Although rarely used now, IS6110 restriction fragment length polymorphism (IS6110 RFLP) has been used in Uganda for the last 15 years, and there is a considerable amount of molecular data stored in this format (Joloba et al. 2000; Niemann et al. 2002). The National TB Program Laboratory and the Mycobacteriology Diagnostic Laboratory in Kampala have also recently acquired sequencing machines that are likely to change the landscape of molecular typing and epidemiology because of the access to the high-throughput data generated by this technique.

22.1

<< | >>
Source: Dibaba A.B., Kriek N.P.J., Thoen C.O. (eds.). Tuberculosis in Animals: An African Perspective. Springer,2019. — 453 p.. 2019
More medical literature on Medic.Studio

More on the topic Tuberculosis Caused by M. bovis in Humans in Uganda:

  1. Chapter 22 Holes and Patches: An Account of Tuberculosis Caused by Mycobacterium bovis in Uganda
  2. Zoonotic (M. bovis) TB in Humans in Cameroon
  3. Bovine Tuberculosis in Uganda
  4. Molecular Epidemiology of M. bovis in Humans and Other Hosts in Africa
  5. Mycobacterium bovis Infection in Humans
  6. Molecular Epidemiology of Bovine Tuberculosis in Uganda
  7. Policy Provisions for Bovine and Zoonotic Tuberculosis in Uganda
  8. Epidemiology of BTB Caused by M. bovis in Burkina Faso
  9. Mycobacterium bovis Infection in Humans in Egypt
  10. Tuberculosis in humans and animals is an ancient contagious disease, with a worldwide distribution.
  11. TUBERCULOSIS, MYCOBACTERIUM BOVIS AND MYCOBACTERIUM CAPRAE INFECTIONS
  12. Manifestation of the Disease in Humans
  13. Cattle Movement Networks in Uganda
  14. Inferences on the Origin of M. bovis
  15. Geography, Demography, and Livestock Systems in Uganda
  16. Public Heath Implication of M. bovis
  17. Human TB Due to M. bovis
  18. Microscopic Detection of M. bovis
  19. 6.3 Virulence of the MTC and Risk of Infection to Humans and Animals